Radiomics analysis of baseline computed tomography to predict oncological outcomes in patients treated for resectable colorectal cancer liver metastasis
PLOS ONE · 11.09.2024 · 19 (9) · e0307815
DOI: 10.1371/journal.pone.0307815 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, online erschienen am 11.09.2024. Verfasst von Emmanuel Montagnon und 13 weiteren Autor:innen. Beteiligte Einrichtung: Centre de recherche du Centre hospitalier de l'Université de Montréal (CRCHUM), Montréal, QC, Canada. Hauptthemen laut MEDLINE: Liver Neoplasms, Colorectal Neoplasms, Tomography, X-Ray Computed. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fonds de Recherche du Québec - Santé, Institut de Valorisation des Données, Université de Montréal Roger Des Groseillers Research Chair in Hepatopancreatobiliary Surgical Oncology.
Abstract (Originalsprache)
Objective
The purpose of this study was to determine and compare the performance of pre-treatment clinical risk score (CRS), radiomics models based on computed (CT), and their combination for predicting time to recurrence (TTR) and disease-specific survival (DSS) in patients with colorectal cancer liver metastases.
Methods
We retrospectively analyzed a prospectively maintained registry of 241 patients treated with systemic chemotherapy and surgery for colorectal cancer liver metastases. Radiomics features were extracted from baseline, pre-treatment, contrast-enhanced CT images. Multiple aggregation strategies were investigated for cases with multiple metastases. Radiomics signatures were derived using feature selection methods. Random survival forests (RSF) and neural network survival models (DeepSurv) based on radiomics features, alone or combined with CRS, were developed to predict TTR and DSS. Leveraging survival models predictions, classification models were trained to predict TTR within 18 months and DSS within 3 years. Classification performance was assessed with area under the receiver operating characteristic curve (AUC) on the test set.
Results
For TTR prediction, the concordance index (95% confidence interval) was 0.57 (0.57–0.57) for CRS, 0.61 (0.60–0.61) for RSF in combination with CRS, and 0.70 (0.68–0.73) for DeepSurv in combination with CRS. For DSS prediction, the concordance index was 0.59 (0.59–0.59) for CRS, 0.57 (0.56–0.57) for RSF in combination with CRS, and 0.60 (0.58–0.61) for DeepSurv in combination with CRS. For TTR classification, the AUC was 0.33 (0.33–0.33) for CRS, 0.77 (0.75–0.78) for radiomics signature alone, and 0.58 (0.57–0.59) for DeepSurv score alone. For DSS classification, the AUC was 0.61 (0.61–0.61) for CRS, 0.57 (0.56–0.57) for radiomics signature, and 0.75 (0.74–0.76) for DeepSurv score alone.
Conclusion
Radiomics-based survival models outperformed CRS for TTR prediction. More accurate, noninvasive, and early prediction of patient outcome may help reduce exposure to ineffective yet toxic chemotherapy or high-risk major hepatectomies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Centre de recherche du Centre hospitalier de l'Université de Montréal (CRCHUM), Montréal, QC, Canada.
- Department of Radiology, CISSS des Laurentides, Hôpital de Saint-Eustache, Saint-Eustache, QC, Canada.
- Department of Radiology, Radiation Oncology and Nuclear Medicine, Université de Montréal, Montréal, QC, Canada.
- MedICAL Laboratory, Polytechnique Montréal, Montréal, QC, Canada.
- Division of Internal Medicine, Department of Medicine, Hôpital du Sacré-Cœur-de-Montréal, Montréal, QC, Canada.
- Montreal AI Hub, Ericsson Canada, Montréal, QC, Canada.
ORCID-Profile: Edmond Rafie, An Tang
Förderung
- Fonds de Recherche du Québec - Santé
- Institut de Valorisation des Données
- Université de Montréal Roger Des Groseillers Research Chair in Hepatopancreatobiliary Surgical Oncology
Zitieren
APA
Montagnon, E., Cerny, M., Hamilton, V., Derennes, T., Ilinca, A., Elforaici, M. E. A., Jabbour, G., Rafie, E., Wu, A., Perdigon Romero, F., Cadrin-Chênevert, A., Kadoury, S., Turcotte, S., & Tang, A. (2024). Radiomics analysis of baseline computed tomography to predict oncological outcomes in patients treated for resectable colorectal cancer liver metastasis. PLOS ONE, 19(9), e0307815. https://doi.org/10.1371/journal.pone.0307815
Vancouver
Montagnon E, Cerny M, Hamilton V, Derennes T, Ilinca A, Elforaici MEA, et al. Radiomics analysis of baseline computed tomography to predict oncological outcomes in patients treated for resectable colorectal cancer liver metastasis. PLOS ONE. 2024;19(9):e0307815. doi:10.1371/journal.pone.0307815
BibTeX
@article{Montagnon2024,
author = {Montagnon, Emmanuel and Cerny, Milena and Hamilton, Vincent and Derennes, Thomas and Ilinca, André and Elforaici, Mohamed El Amine and Jabbour, Gilbert and Rafie, Edmond and Wu, Anni and Perdigon Romero, Francisco and Cadrin-Chênevert, Alexandre and Kadoury, Samuel and Turcotte, Simon and Tang, An},
title = {Radiomics analysis of baseline computed tomography to predict oncological outcomes in patients treated for resectable colorectal cancer liver metastasis},
journal = {PLOS ONE},
year = {2024},
volume = {19},
number = {9},
pages = {e0307815},
doi = {10.1371/journal.pone.0307815}
}
EUVIMED